Roberto Iacone is the founder of Alentis Therapeutics. Alentis Therapeutics has raised $366M in total funding. Latest round: Series D.
Roberto Iacone is the Chief Executive Officer and Director at Alentis Therapeutics AG. He is also identified as a founder of Bright Peak Therapeutics AG and Ridgeline Therapeutics, and is a Venture Partner at Pureos Partners AG. He has publicly announced Alentis financing milestones, including the company’s Series C round.
Full founder directory · Investor directory · Company funding database · Fundraising library